Tumor-specific CD8 T cell characterization in HR<sup>+</sup> breast cancer reveals an impaired antitumoral response in patients with lymph node metastasis.

Cell Rep Med · 2025 · PMC12432377 · PMID 40730190

Europe PMC DOI

hedged sentence

0.2659

closest p · 5.3× alpha

0.2659

boldest claim

The sentences

did not reach statistical significancep = 0.2659not close (p > 0.1)

A similar trend was uncovered in the second dataset, although the difference did not reach statistical significance ( p = 0.2659).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Tumor-specific CD8 T cell characterization in HR&lt;sup&gt;+&lt;/sup&gt; breast cancer reveals an impaired antitumoral response in patients with lymph node metastasis.

The sentences

Tumor-specific CD8 T cell characterization in HR<sup>+</sup> breast cancer reveals an impaired antitumoral response in patients with lymph node metastasis.